76 related articles for article (PubMed ID: 18074862)
1. Evaluation of retinoblastoma protein expression in endometrial hyperplasia.
Brucka A; Bartczak P; Sporny S
Pol J Pathol; 2007; 58(3):173-82. PubMed ID: 18074862
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical pattern of protein P21, cyclin D1 and cyclin E in endometrial hyperplasia.
Brucka A; Bartczak P; Ratyńska M; Sporny S
Pol J Pathol; 2009; 60(1):19-25. PubMed ID: 19670700
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].
Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II
Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374
[TBL] [Abstract][Full Text] [Related]
4. RB protein expression in human endometrial carcinomas--an immunohistochemical study.
Semczuk A; Schneider-Stock R; Miturski R; Skomra D; Tomaszewski J; Roessner A; Jakowicki JA
Pathol Res Pract; 2000; 196(1):41-6. PubMed ID: 10674271
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone-related peptide (PTH-rp) in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Shabani N; Richter DU; Jeschke U; Briese V; Friese K
Anticancer Res; 2005; 25(3A):1633-8. PubMed ID: 16033073
[TBL] [Abstract][Full Text] [Related]
6. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
Vereide AB; Kaino T; Sager G; Arnes M; Ørbo A
Gynecol Oncol; 2006 May; 101(2):214-23. PubMed ID: 16325240
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma protein expression in endometrial hyperplasia and carcinoma.
Niemann TH; Yilmaz AG; McGaughy VR; Vaccarello L
Gynecol Oncol; 1997 May; 65(2):232-6. PubMed ID: 9159330
[TBL] [Abstract][Full Text] [Related]
8. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
9. Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma.
Hamid AA; Mandai M; Fujita J; Nanbu K; Kariya M; Kusakari T; Fukuhara K; Fujii S
Int J Gynecol Pathol; 2003 Jul; 22(3):240-7. PubMed ID: 12819390
[TBL] [Abstract][Full Text] [Related]
10. Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue.
Mylonas I; Makovitzky J; Shabani N; Richter DU; Kuhn C; Jeschke U; Briese V; Friese K
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):101-8. PubMed ID: 15596282
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.
Götte M; Wolf M; Staebler A; Buchweitz O; Kelsch R; Schüring AN; Kiesel L
J Pathol; 2008 Jul; 215(3):317-29. PubMed ID: 18473332
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of the tumour marker CA-125 in normal, hyperplastic and malignant endometrial tissue.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Anticancer Res; 2003; 23(2A):1075-80. PubMed ID: 12820350
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of Retinoblastoma gene product in normal, hyperplastic and malignant endometrium. Correlation with p53 protein expression, c-erbB-2, hormone receptors' status and proliferative activity.
Ioachim EE; Goussia AC; Kitsiou EG; Charalabopoulos K; Mermiga E; Stefanaki S
Dis Markers; 2002; 18(3):143-52. PubMed ID: 12515910
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma (pRb) protein immunoexpression in colorectal cancer.
Chetty R; Subramoney T; Singh J; Harilal P
Anticancer Res; 1997; 17(4A):2593-7. PubMed ID: 9252686
[TBL] [Abstract][Full Text] [Related]
15. Expression of immunoreactivity and genetic mutation in eosinophilic and ciliated metaplastic changes of endometrial glandular and stromal breakdown: cytodiagnostic implications.
Shimizu K; Norimatsu Y; Kobayashi TK; Sakurai M; Ogura S; Yoshizawa A; Miyamoto T; Miyake Y; Aratake Y; Sakaguchi T; Ohno E
Ann Diagn Pathol; 2009 Apr; 13(2):89-95. PubMed ID: 19302956
[TBL] [Abstract][Full Text] [Related]
16. Calretinin: an immunohistochemical marker for the normal functional endometrial stroma and alterations of the immunoreactivity in dysfunctional uterine bleeding.
Al Moghrabi H; Elkeilani A; Thomas JM; Mai KT
Pathol Res Pract; 2007; 203(2):79-83. PubMed ID: 17188434
[TBL] [Abstract][Full Text] [Related]
17. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer.
Song JY; Kim JW; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW
Acta Obstet Gynecol Scand; 2008; 87(8):862-7. PubMed ID: 18704778
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress in endometrial hyperplasia.
Gómez-Zubeldia MA; Bazo AP; Gabarre JJ; Nogales AG; Palomino JC
Menopause; 2008; 15(2):363-8. PubMed ID: 17893631
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the p16INK4a/cyclin D1/RB pathway in gastrointestinal tract endocrine tumors.
Li AF; Li AC; Tsay SH; Li WY; Liang WY; Chen JY
Am J Clin Pathol; 2008 Oct; 130(4):535-42. PubMed ID: 18794045
[TBL] [Abstract][Full Text] [Related]
20. Endometrial glandular and stromal breakdown, part 1: cytomorphological appearance.
Shimizu K; Norimatsu Y; Kobayashi TK; Ogura S; Miyake Y; Ohno E; Sakurai T; Moriya T; Sakurai M
Diagn Cytopathol; 2006 Sep; 34(9):609-13. PubMed ID: 16900469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]